Monte Rosa Therapeutics, Inc. (($GLUE)) announced an update on their ongoing clinical study. Monte Rosa Therapeutics, Inc. is conducting a Phase ...

Monte Rosa Therapeutics (GLUE) announced the company will present preclinical data on the potential of MRT-8102 at the American Heart ...

Results of the MRT-6160 Phase 1 SAD/MAD study demonstrate deep VAV1 degradation of greater than 90%, significant T and B cell functional inhibition as well as significant inhibition of cytokine ...

Lowell’s Merrimack Repertory Theatre (MRT) begins its 2023-24 season with the world premiere of award-winning playwright Steven Deitz’s “Gaslight.” Produced in partnership with the Cincinnati ...